However, in pancreatic ductal adenocarcinoma, studies have demonstrated that the inhibition or deletion of NLRP3, ASC, or caspase-1 decreases tumor growth and metastasis by reprogramming innate and adaptive immunity in the tumor microenvironment [48]. The gene discussed is CASP1; the disease is neoplasm.